12 insiders have filed at CHKP since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Shwed Gil | Director | 24.87M | 22.627% | none | none |
| Greenberg Itay | Chief Revenue Officer | 84.5k | 0.077% | none | none |
| Zafrir Nadiv | Chief Executive Officer | 55.9k | 0.051% | none | none |
| Golan Roei | Chief Financial Officer | 38.9k | 0.035% | none | none |
| Kremer Nataly | Chief Product Officer | 21.9k | 0.02% | none | none |
| Ungerman Jerry T | Director | 16.2k | 0.015% | none | none |
| Ozer-Armon Tzipi | Director | 4.4k | <0.01% | none | none |
| Rothrock Ray A. | Director | 4.0k | <0.01% | none | none |
| Shavit Shenhav Tal | Director | 4.0k | <0.01% | none | none |
| Chelouche Yoav | Director | 4.0k | <0.01% | none | none |
| Smith Jill D. | Director | 3.1k | <0.01% | none | none |
| Gruber Dafna | Director | 1.9k | <0.01% | none | none |
No open-market buys or sells have been reported at CHKP since 2023Q3. The table shows the filed stakes; it updates when an insider files.
Full register at boothcheck.com/insiders/CHKP. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.